MIRA
Mira Pharmaceuticals, Inc.
$0.95
0.00 (-0.21%)
At close · Jul 2
Market Cap
$39.70M
Shares
42,022,087
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.95
Open$0.93
Day$0.92–0.95
52W$0.90–2.45
Avg vol 30d109K
Short int275K · 0.7% float · 2.7d
Short vol19%
DataAug 2023–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−24% below
−
Price vs 50-day avg
−5% below
◦
RSI (14)
46 · neutral
+
MACD trend
positive
−
52-week position
3% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $1 › 200d $1 — 200d above 50d
+
Institutional flow
+4% holders QoQ · +7 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.65% of float · ▼ -25.3% MoM · 2.7 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
26 holders — mid 3-yr range
Fundamentals
Fair
−
EPS growth
−165% Y/Y
+
Balance sheet
net cash $6.3M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−24% below
Bearish
Price vs 50-day avg
−5% below
Bearish
RSI (14)
46 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.65% of float · ▼ -25.3% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
26 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 3%
52-wk high $2
vs 200-day avg -24%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - General — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MIRA
this stock
Mira Pharmaceuticals, Inc.
|
$39.70M | -37.4% | — | — | 0.7% |
|
LLY
ELI LILLY & Co
|
$1.14T | +13.1% | +44.7% | 43.1 | 1.0% |
|
JNJ
Johnson & Johnson
|
$633.19B | +27.8% | +6.0% | 30.5 | 1.1% |
|
ABBV
AbbVie Inc.
|
$461.26B | +15.2% | +8.6% | 128.6 | 1.3% |
|
MRK
Merck & Co., Inc.
|
$311.82B | +24.0% | +1.4% | 35.6 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MIRA | +4.1% | -6.4% | -36.6% | -0.2% | -37.4% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +2.6% | -5.2% | -44.6% | +0.1% | -46.6% |